No Data
Analysts Remain Bullish on Caribou Biosciences (CRBU) Despite Ongoing Slump in Its Shares
Evercore Maintains Caribou Biosciences(CRBU.US) With Hold Rating, Maintains Target Price $3
Evercore ISI Sticks to Their Hold Rating for Caribou Biosciences (CRBU)
Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Caribou Biosciences (CRBU) and CervoMed (CRVO)
Caribou Biosciences Advances CRISPR Therapies Amid Financial Challenges
Express News | Caribou Biosciences Inc : RBC Cuts Target Price to $11 From $14
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
HOHA888 : Hi what do you think is a good TP target? My average is around $1.50
FattyChick OP HOHA888 : >1.70
HOHA888 FattyChick OP : okay thanks!
FattyChick OP HOHA888 : Long term >$6
HOHA888 FattyChick OP : Long term as in? Abt half a year?
View more comments...